The biosynthesis of the carbohydrate precursor of asparagine-linked glycoproteins is initiated by a stepwise, dolichol phosphate-linked assembly of Glc3Man9GlcNAc2 unit in the endoplasmic reticulum (ER) and its transfer en bloc to the asparagine residue in the sequon, Asn-X-Ser/Thr in the nascent polypeptide on the lumenal face of the ER. This is followed by co- and posttranslational processing reactions that begin with the excision of the glucosyl residues by ER-localized glucosidases (Kornfeld and Kornfeld, 1985). The incipient glycoprotein may not undergo any additional modification, fold, and be transported as such through the secretory pathway. More commonly, depending on the structural features of the underlying polypeptide, extensive modifications of the carbohydrate moiety of the glycosylated polypeptide occur in the rough ER and Golgi compartment; these involve the action of processing mannosidases, present in both RER and the Golgi, and glycosyltransferases within the different subcompartments of the Golgi and trans-Golgi network, culminating in the biosynthesis of high mannose, complex and hybrid glycoproteins that are transported to their intra- or extracellular sites of destination (Moremen et al., 1994).
Glucosidase I catalyzes the onset of processing reactions by clipping the terminal [alpha]1,2-linked glucosyl residue even as early as the polypeptide is still undergoing synthesis on the polysomes and translocating into the lumen of the ER (Atkinson and Lee, 1984). Later, glucosidase II sequentially removes the internal [alpha]1,3-linked glucosyl residues (Kornfeld and Kornfeld, 1985; Moremen et al., 1994). An alternative pathway utilizes an endomannosidase that can remove Glc3-1Man fragment from the newly synthesized glycosylated polypeptide (Lubas and Spiro, 1987; Fujimoto and Kornfeld, 1991). A model has been proposed according to which the action of the processing glucosidases, after the removal of two of the three glucosyl residues, allows the binding of the Glc1Man9GlcNAc2-polypeptide by the lectin-chaperones calnexin and calreticulin followed by other chaperones such as BiP, for the proper folding and maturation of glycoproteins during transport in the secretory pathway (Kim and Arvan, 1995; Rodan et al., 1996; Oliver et al., 1997). For quality control purposes, this model also invokes the additional participation of an ER-localized UDP-Glc: glycoprotein glucosyltransferase that can reglucosylate a deglucosylated but partially folded or malfolded glycoprotein and allow a rebinding by calnexin and calreticulin to ensure proper folding (Sousa et al., 1992; Rodan et al., 1996). The folded glycoprotein is perceived to dissociate from the lectin-chaperones, as glucosidase II cleaves the innermost [alpha]1->3Glc before the egress of the glycoprotein from the ER.
Because of the critical role in initiating the processing and maturation phase during the biosynthesis of N-linked glycoproteins, glucosidase I may be regarded as a potential candidate for the regulation of their biosynthesis. The study of protein N-glycosylation during the ontogeny of the mammary gland has been a long term focus of our laboratory. Biochemical investigations on glucosidase I in our and others' laboratories have concentrated on the purification and characterization of the enzyme from different animal tissues and yeast (Bause et al., 1986, 1989; Shailubhai et al., 1987). In the mammary gland, it is a tetrameric N-linked glycoprotein with a subunit molecular mass of 85 kDa. Its topology was defined to have a lumenally-oriented catalytic domain, a transmembrane segment and a short, cytoplasmic tail (Shailubhai et al., 1991). The active site of the enzyme is contained within a 39 kDa segment, obtained by tryptic digestion of the purified protein. Glycosylation is not absolutely required for its catalytic activity. A tagging strategy delineated the presence of a cysteine residue at the substrate binding region within the active site of the enzyme (Pukazhenthi et al., 1993). Substrate protection followed by chemical modification of the side chains of amino acids on the surface of the enzyme also implicated the involvement of an arginine and a tryptophan residue at the oligosaccharide binding site (Romaniouk and Vijay, 1997). The data on the cDNA of glucosidase I, recently cloned from the human brain, is in agreement with the proposed topology, and predicts the enzyme to be a type II membrane protein (Kalz-Fuller et al., 1995). Conspicuously, of the three cysteines at positions 136, 601, and 816 in the polypeptide predicted from the cDNA sequence of the human brain enzyme, cysteine 601 is flanked by arginine and tryptophan and is within the active site-containing domain. These observations were combined with the information in the protein sequence data banks for the putative glucosidase I gene in C.elegans to propose a nine amino acid motif, ERHLDLRCW, within the catalytic cleft, as constituting the active site region of glucosidase I that binds the oligosaccharidyl moiety of the immature glycoprotein for processing (Pukazhenthi et al., 1993; Romaniouk and Vijay, 1997). A recent comparison of the product of the yeast gene, CWH41, with the human glucosidase I indicated that the gene encodes glucosidase I (Romero et al., 1997).
To meet the demands of the secretion of large amounts of soluble and membrane glycoproteins into milk, there is an enormous increase in glycoprotein synthesis in the mammary gland during lactation. Several key enzymes of the dolichol cycle and glucosidase I are coordinately upregulated during the ontogeny of the gland in the mouse, with peak activities observed at mid-lactation (Vijay and Oka, 1986; Shailubhai et al., 1990). Using an explant culture system to mimic lactogenesis, in a previous study, we showed that glucosidase I is regulated during the hormonally modulated differentiation of the explants of the rat mammary gland (Shailubhai et al., 1990). The maximum activation was obtained by the synergistic action of the lactogenic hormones, insulin, prolactin, and hydrocortisone in the culture medium. To further elucidate the molecular mechanisms involved in the developmental and a potential hormonal regulation of the enzyme in the mammary gland, it is important to isolate its gene and procure the promoter. This study describes the structure, organization, size of the transcript, and an analysis of the promoter of the gene for the enzyme in the mouse.
Genomic Southern analysis
To estimate the size and copy number of mouse glucosidase I gene a Southern blot of mouse genomic DNA digested with restriction enzymes (EcoRI, BamHI, HindIII, KpnI, and PstI), was probed with the partial cDNA of rat ovary glucosidase I under conditions of high stringency (Figure
Figure 1. Southern analysis of mouse genomic DNA. Mouse genomic DNA (10 µg/lane) was either not digested or digested with EcoRI, BamHI, HindIII, KpnI, and PstI; transferred onto nitrocellulose membrane; and probed with the partial cDNA of rat glucosidase I. Isolation and characterization of mouse glucosidase I gene
In order to study the regulation of glucosidase I in the mouse mammary gland, it was necessary to isolate the genomic sequence with the promoter. The partial cDNA of rat ovary enzyme was used to screen a [lambda] EMBL3 SP6/T7 mouse genomic library. A screening of 1 million plaques generated five clones: [lambda] 4, 5, 10, 12, and 16. To determine whether one of the clones contained the complete gene, the isolated clones were further subjected to Southern analysis with 5[prime] and 3[prime] oligonucleotide probes from the rat cDNA clone as given in Materials and methods. Clone [lambda]5 showed positive fragments of 4.2 and 2.6 kb on autoradiogram for 5[prime] and 3[prime] oligonucleotide probes, respectively, indicating that it was the longest clone. These DNA inserts were subcloned in pGEM®-7Zf(-) vector and designated as 5a and 3a for 5[prime] and 3[prime] region of the gene for further analysis. Genomic organization of mouse glucosidase I gene
DNA sequencing of subclones 5a and 3a, and a comparison of the resulting sequence with human glucosidase I cDNA (Kalz-Fuller et al., 1995) indicated that the entire mouse glucosidase I gene was present in clone 5; it is ~6.8 kb in size, comprising four exons separated by three introns. A schematic diagram of the gene is presented in Figure
Figure 2. Schematic representation of mouse glucosidase I gene. Location of BamHI site, multiple transcription start sites (arrows), exon 1-4 (solid boxes, coding region), intron A,B,C (open boxes), translation initiation (ATG) and termination (TAC) codons, polyadenylation site and 5[prime] and 3[prime] untranslated regions (hatched boxes) are shown. The positive genomic clone [lambda]5, subclones 5a and 3a, and the scale in kilobase pairs are defined by lines. Analysis of 5[prime] flanking region
An examination of the 5[prime] noncoding region reveals that it lacks a canonical TATA box but contains other well characterized features of a promoter, shown underlined and in boldface letters in Figure
Table I. Determination of transcription start site
Figure 3. Nucleotide sequence of the 5[prime] flanking region of the mouse glucosidase I gene. The sequence of 5[prime] flanking region of the mouse glucosidase I gene is shown (GenBank accession number AF 001719). Numbering of nucleotides is relative to adenosine (taken as +1) of translation initiation codon ATG. Primer used for primer extension is double underlined. Multiple transcription start sites are indicated by arrows. Sequences that share homology to known transcription factor binding sites are boldface and underlined. Generic STAT factor binding sites are boxed. Regions -1164 to -1101 and -1399 to -1359 are underlined.
Figure 4. Identification of transcription initiation site of mouse glucosidase I gene by primer extension and ribonuclease protection assay. The RNase protection assay was performed using a [32P]labeled riboprobe generated by an in vitro transcription reaction and subsequently purified as described under Materials and methods. The riboprobe was hybridized overnight with total RNA of mouse mammary gland and yeast tRNA as a control at 37°C, both samples were digested with RNase A and RNase T1, and riboprobe alone was also treated in a similar fashion. The digested products were denatured and electrophoresed on 6% polyacrylamide gel. lane 1, [32P]labeled [phis]X174/Hinf I markers; lane 2, total RNA + riboprobe; lane 3, yeast tRNA + riboprobe; and lane 4, riboprobe alone.
The transcription start site(s) was determined by primer extension analysis using primer PR-2, positioned 10 bp upstream of the translation initiation codon ATG, with total mouse mammary RNA as the template. Three extended products of 150, 156, and 272 bp in size were obtained, suggesting the presence of multiple initiation sites for the transcription of the gene (data not shown). The same results were observed consistently in three repetitions of the experiment. No primer extension product was observed with tRNA in the control lane. RNase protection assay was performed to confirm the results of primer extension. An RNase protected fragment of 140 bp was identified on the sequencing gel as the major band. No protection was observed for control tRNA (Figure
Figure 5. Analysis of 5[prime] noncoding region of mouse glucosidase I gene by RT-PCR. (A) Schematic representation of the position of primers selected for PCR and sizes of the expected PCR products are shown. Vertical arrows show position of transcription start sites determined by primer extension and horizontal arrows denote location of PCR primers. (B) Total RNA from mouse mammary gland was reverse transcribed into cDNA (depicted as lane R) and subjected to PCR. Genomic DNA was used as template for positive control marked as lane C. Negative control received no DNA (Lane N). Lane M shows 1 kb DNA ladder. Northern blot analysis of glucosidase I
The levels of glucosidase I mRNA in various tissues were determined by northern hybridization (Figure
Figure 6. Northern blot analysis to determine the size of glucosidase I transcript in mouse tissues. Northern blot with 10 µg of Poly [A+] RNA was probed with rat glucosidase I cDNA. Analysis of promoter activity
To determine the promoter activity, the glucosidase I promoter construct, Glu I (-2114/-5) pCAT was assayed by transient transfection into COS 7 cells. [beta]-Casein gene promoter construct was used as positive control. Both the constructs showed positive activity, whereas pCAT basic vector had no activity when assayed under similar conditions (Figure
Figure 7. Promoter activity of mouse glucosidase I gene. Glucosidase I promoter construct Glu I (-2114/-5) pCAT was cotransfected with PSTc GR 3-795, pRc/CMV and STAT 5a pXM expression vectors into COS 7 cells. p[beta]c(-282/-82) CAT promoter construct was used as a positive control under similar conditions. Lane 1, Glucosidase I; lane 2, [beta]-casein; lane 3, pCAT vector.
A differential expression of a constellation of more than 100 glycosyltransferases and glycosidases is required for the elaboration of the extensive repertoire of glycoconjugate structures in mammalian cells. An ensemble of some seventeen glycosyltransferases of the dolichol cycle and two glucosidases, viz., glucosidases I and II, participating in concert, is minimally required for the biosynthesis of all N-linked glycoproteins (Kornfeld and Kornfeld, 1985; Moremen et al., 1994). Among these enzymes, glucosidase I is critically juxtapositioned to trigger the posttranslational processing of the oligosaccharide moiety and set the stage for the folding and maturation phase of these glycoproteins in the secretory pathway. Therefore, a study of the structure-function and the regulation of glucosidase I would appear to be important for understanding the overall assembly of N-linked glycoproteins. The present study has focused on isolating the gene of the enzyme as a prelude to studying its regulation during the growth and differentiation of the mouse mammary gland.
The structural organization of glucosidase I gene shows a relationship with the functional domains of the enzyme. The first exon codes for the cytoplasmic tail and transmembrane domain of the enzyme, the second and third exons encode the amino acid residues 116 through 192 and 193 through 257, respectively, whereas the fourth exon encodes the putative catalytic domain containing both the active and the glycosylation sites (Shailubhai et al., 1991; Pukazhenthi et al., 1993; Romaniouk and Vijay, 1997). At present, no clear function can be assigned to second and third exons. The organization of the exons correlates well with the biochemical studies on the topology of glucosidase I (Shailubhai et al., 1991). Comparison of the mouse glucosidase I coding region with the corresponding sequence of the human cDNA shows 84% homology (GenBank AF001719).
Analysis of the 5[prime] flanking region reveals that it lacks a TATA box, and possesses a perfect CCAAT box, located at position -870. This is much farther upstream than the typical location of the CCAAT box, usually ~80 nucleotides upstream from the transcription start site. The proximal region of the promoter comprising 176 bp upstream of the translation initiation codon ATG, is 71% rich in GC content, and contains two Sp1 binding sites, and three sites for binding by ETF. These are typical features of housekeeping gene promoters. Indeed, the results of primer extension analysis and RT-PCR confirm the presence of multiple transcription start sites in the promoter. These observations are explicable, given the ubiquitous requirement for glucosidase I in the biosynthesis of N-linked glycoproteins by eukaryotic cells. Earlier, the genes for UDP-GlcNAc: dolichol-P GlcNAc-1-P transferase, the enzyme that catalyzes the first step for the assembly of the oligosaccharide unit of N-linked glycoproteins, and the Golgi-localized UDP-Gal:polypeptide acceptor galactosyl transferase involved in the biosynthesis of complex glycoproteins, were shown to have housekeeping promoters (Shaper et al., 1988; Rajput et al., 1994a). Binding elements for a number of well-known transcription factors, e.g., NF[kappa]B, AP2, half-sites for progesterone receptor (PR), and estrogen receptor are also present in the glucosidase I promoter. The size of the major transcript for glucosidase I expression was determined to be 3.1 kb by Northern analysis. These data as well as the results of ribonuclease protection assay indicate that glucosidase I gene is predominantly transcribed from a single transcription site.
In recent years, the Jak/Stat signal transduction pathway has been shown to induce the transcriptional activation of many genes. In this paradigm, cytokines, hormones, and growth factors bind their respective member of the transmembrane cytokine receptor superfamily, and activate an intracellular Janus protein tyrosine kinase (Jak) to tyrosine-phosphorylate an intracellular signal transducer and activator of transcription (Stat) (Darnell, 1997). An interaction of Stat protein with the SH2 domain of a dimerization partner confers on (Stat)2 the ability to bind DNA at the Stat-binding element and induce transcription. Jak2 and Stat5 have been identified for signaling by prolactin (Campbell et al., 1994; Rui et al., 1994; Waters et al., 1995). The transcription of genes during lactogenic differentiation of the mammary gland, involves the synergistic action of prolactin and glucocorticoid, operating through the Jak2/Stat5 signal transduction pathway (Darnell, 1997). Transactivation mediated by GR usually requires the binding of dimeric receptor molecules to the palindromic inverted repeat DNA-binding sites, and half-sites binding monomeric GR complexes were considered to be insufficient by themselves to confer hormone responsiveness (Stöcklin et al., 1996). However, monomeric GR molecules binding to the receptor half-palindromic sites were proposed to gain competence as transcriptional activators by interacting with other transcription factors (Slater et al., 1993). GR half-palindromic sites were found to recruit monomeric GR molecules to the [beta]-casein gene promoter and shown to be instrumental in mediating the synergistic effect between glucocorticoids and prolactin for [beta]-casein gene activation (Lechner et al., 1997). In the -1164 to -1101 segment of glucosidase I promoter given above, the two underlined nonads have the generic sequence, TTN5AA that is minimally required for binding by a Stat dimer. The proximity of what may be otherwise two weak but close-neighbor (Stat)2 binding sites, to a potentially strong candidate dimeric GR-binding site, and certainly a monomeric GR binding half-site raises the possibility that this region represents a portion of the promoter where a (Stat)2 or a (Stat)2-(Stat)2 tetramer may form, and interact with the bound GR in close proximity by protein-protein interaction to give a synergized activation of glucosidase I gene expression, as observed during lactogenic induction by glucocorticoid and prolactin in mammary explant culture (Shailubhai et al., 1990).
Another region within the glucosidase I promoter, viz.
Steroid hormone receptors generally bind to hormone response elements composed of two half-sites organized as a palindrome with a three nucleotide spacer, while nonsteroid hormone receptors preferentially bind to hormone response elements composed of two half-sites organized as a direct repeat, with the number and composition of the nucleotides separating the half-sites serving as important determinants of receptor selectivity (Stöcklin et al., 1996). There is presently no known receptor that binds a DR7 motif of the type in the promoter segment, -1399 to -1359. Thus, the above region in glucosidase I promoter might represent the binding site for a yet-to-be-discovered receptor (perhaps a new orphan receptor). Recently, an orphan nuclear receptor activated by pregnanes has been proposed to define a novel steroid signaling pathway (Kliewar et al., 1998). This receptor binds to a conserved region within the promoters of genes, CYP3A1 and CYP3A2, that encode cytochrome P450 hemoproteins involved in the hydroxylation of steroids. This region does not contain a typical glucocorticoid response element, but instead contains a DR of the nonsteroid nuclear receptor half-site sequence AGTTCA separated by a three-nucleotide spacer (DR3). Alternatively, the hexads in the -1399 to -1359 segment of the glucosidase I promoter represent half-sites for binding by the monomeric form of the GR, and their presence has much similarity to the DR12 half-sites,...
Transfection of the glucosidase I promoter fused to CAT reporter gene in COS 7 cells presented in this study clearly demonstrates its transcriptional activity. Future transfection experiments using different deletion constructs of the promoter region of this gene will confirm the role of GR and STAT factors binding elements in hormonal regulation during development at the transcription level.
It is also known that an ER-localized endomannosidase can cleave Glc1-3Man oligosaccharides from the incipient glycoprotein during maturation and can provide an alternative pathway for the initiation of processing and folding during glycoprotein maturation (Lubas and Spiro, 1984; Fujimoto and Kornfeld, 1991). With the availability of the gene of glucosidase I in the mouse, as reported here, it should now be possible to knock out this gene and evaluate the relative significance of the endomannosidase-mediated maturation of N-linked glycoproteins and the essentially of glucosidase I during embryogenesis, growth, and differentiation of eukaryotes. Materials
Mouse genomic library in [lambda] EMBL3 SP6/T7 and human cDNA probe of glyceraldehyde 3 phosphate dehydrogenase (G3PDH) were from Clontech; Trizol reagent, restriction endonucleases, T4 DNA ligase, T4 polynucleotide kinase, deoxynucleotide triphosphates, MMLV reverse transcriptase, Klenow fragment of DNA polymerase I, Taq polymerase, DNA molecular weight markers, tissue culture media, and oligonucleotide primers were from Life Technologies; radioactively-labeled nucleotides and [14C] chloramphenicol were from NEN Life Sciences Products. The vector pGEM®-7Zf(-), pCAT, primer extension kit, riboprobe system, Poly A Tract® mRNA isolation system III, and mouse genomic DNA were from Promega Corporation. [beta]-Casein gene promoter vector p[beta]c (-282/-82) CAT and glucocorticoid receptor expression vector PSTC GR 3-795 were gifts from Dr. Wolfgang Doppler, Institut für Medizinische Chemie und Biochemie, Universität Innsbruck, Fritz-pregl-Strasse 3, A-6020 Innsbruck, Austria. STAT 5a expression vector pXM was kindly provided by Dr. Bernd Groner, Institute for Experimental Cancer Research, Tumor Biology Center Freiburg, D-79106 Freiburg, Germany. Long form prolactin receptor expression vector pRc/CMV was a gift from Dr. Paul Kelly, INSERM, Unité 344, Endocrinologie Moléculaire, Faculté de Médecine, Necker-Enfant Malades, Paris, France. Sequenase version 2.0 DNA sequencing kit was purchased from U.S. Biochemical Corp.; nitrocellulose membranes were from Schleicher & Schuell; Hybond-N+ nylon membranes were from Amersham; Nu-Trap columns were from Stratagene; TA Cloning system was from Invitrogen Corp. The mouse mammary glands were obtained from C3H mice maintained at our animal colony. All other chemicals were from Sigma or Fisher Chemical Co. Southern hybridization
Mouse genomic DNA (10 µg/lane) was digested with the restriction enzymes BamHI, HindIII, EcoRI, KpnI, and PstI; electrophoresed in 0.8% agarose; transferred to nitrocellulose membranes; and hybridized overnight with the partial cDNA probe of rat ovary glucosidase I (GenBank accession no. AF087431) under high stringency condition in 50% formamide, 5× SSPE (0.75 M NaCl, 0.05 M NaH2PO4, (pH 7.4) and 0.005 M EDTA), 5× Denhardt's solution (0.1% Ficoll 400, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin), 10 mg/ml denatured salmon sperm DNA, and 0.5% SDS at 42°C (Khan et al., 1996). cDNA probes were labeled with [[alpha]32P]dCTP using Klenow fragment of DNA polymerase I and random hexamer primers (Feinberg and Vogelstein, 1983). Screening of mouse genomic clone
One million recombinant phages of mouse genomic library were plated for each screening. Duplicate filters were lifted and hybridized with the partial cDNA probe of rat glucosidase I. Five genomic clones, [lambda] 4, 5, 10, 12, and 16, were isolated by the screening. The clones were plaque-purified and bacteriophage DNA was purified by the method of Meese (Meese et al.,1990). Each genomic clone was analyzed by Southern hybridization with [32P] labeled oligonucleotide primer selected from 5[prime] and 3[prime] end of the rat cDNA clone used for library screening. Subclones 5a and 3a, progenitors of [lambda] 5 clone, were found to be positive by Southern analysis and used for further experiments. Primer extension
Primer extension was carried out using oligonucleotide primer PR-2 (5[prime] TGCACGCTTCCCCGGCTGCCACCGTGCGGT 3[prime]) according to manufacturer's instructions (Promega Corp.). Position of the primer is shown in Figure Reverse transcription- polymerase chain reaction (RT-PCR)
First strand cDNA was synthesized with MMLV reverse transcriptase using mouse mammary gland total RNA as a template and random hexamer primers. For 5[prime] transcription start analysis, first strand cDNA equivalent to 1 µg of total RNA was subjected to PCR with 10 pmol of sense primers UP-1 (5[prime] ACCAGCCACAGCGCTTCC 3[prime]) and UP-2 (5[prime] TGCCACGACCTGGGTAAG3[prime]), and the antisense primer UP-0 (5[prime] AGCGCGCGTCGCCTCTCG 3[prime]). Genomic subclone 5a was used as a template for positive control; no template DNA was added in the negative control. Ribonuclease protection assay
A PCR product of 382 bp was generated using genomic subclone 5a as a template and UP0/UP2 as forward and reverse primers located at positions +26 and -353 from translation initiation site, respectively. It was sequenced completely to confirm its sequence. This fragment was subcloned in pGEM®-7Zf(-) vector at XhoI and HindIII site (RB-8). The plasmid was linearized with XhoI to generate the riboprobe using [[alpha]-32P] CTP and Promega's riboprobe system. Riboprobe was digested with RQ1 DNase and purified on NuTrap purification column (Stratagene). Following overnight hybridization to 50 µg total RNA of mouse mammary gland at 37°C, the reaction products were digested with RNase A and RNase T1 as described previously (Sambrook et al., 1989). The resultant products were separated on a 6% polyacrylamide, 8 M urea gel in parallel with [32P] labeled [phis]X174/Hinf I DNA markers. Yeast tRNA was hybridized with equal amount of riboprobe as a control. Chloramphenicol acetyltransferase construct
Glucosidase I gene promoter construct was prepared by subcloning PstI and XbaI cut product of PCR in corresponding sites of pCAT Basic vector designated as Glu I (-2114/-5) pCAT.+ Genomic subclone 5a was used as a template for PCR amplification reaction. The upstream primer was complementary to 18 bp starting at -2114 flanked by PstI site and six additional nucleotides in 5[prime] end. The downstream primer was complementary to the 5[prime] noncoding sequence (-22 to -5) of mouse glucosidase I gene flanked by XbaI site and six additional nucleotides in the 5[prime] end. Cell culture and transfection
COS 7 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1× penicillin, streptomycin, and neomycin antibiotics. After reaching 80% confluency, cells were cotransfected with 20 µg of plasmid DNA containing 5 µg each of Glu I (-2114/-5) pCAT, PSTC GR 3-795, prolactin receptor pRc/CMV, and STAT 5a pXM expression vectors per 100 mm plate, by the calcium phosphate precipitation method (Sambrook et al., 1989). Transfection with [beta]-casein gene promoter construct p[beta]c (-282/-82) CAT (5 µg) was used as a positive control under similar conditions. Cells were washed with cold PBS and harvested using a cell scraper in 0.25 M Tris-HCl, (pH 7.8) at 4°C. Cell lysate was prepared by freeze-thaw followed by centrifugation at 12,000 × g for 20 min. The supernatant was used for CAT activity assay. CAT assay
CAT activity in the culture lysates was measured as described previously (Sambrook et al., 1989). The incubation mixture contained 75 µg of cell lysate, 50 µl of 1 M Tris-HCl (pH 7.8), 10 µl of [14C] chloramphenicol (50 mCi/mmol; 0.1 mCi/ml), and 20 µl of 4 mM acetyl CoA in a final volume of 130 µl. The reaction was carried out at 37°C overnight. Reaction products were separated on TLC in the solvent system, chloroform:methanol (95:5), and exposed to x-ray film. Signals on the autoradiogram were quantitated by laser scanning computing densitometer (Molecular Dynamics). Each assay was conducted at least three times. Northern blot analysis
Mouse total RNA was isolated from various tissues using Trizol reagent according to manufacturer's instructions. Poly [A+] RNA was isolated by Poly A Tract® mRNA system III kit from Promega. Poly [A+] RNA (10 µg) was electrophoresed on denaturing formaldehyde- agarose gel, transferred to Hybond-N+ (Amersham) membrane filter. It was hybridized to [32P] labeled rat cDNA probe according to Church and Gilbert (Church and Gilbert, 1984).
We acknowledge the assistance of Dr. John Gardner for his help in sequencing the genomic clones, Dr. Sheng-guo Li for helpful discussions, and Ms. Margaret Kempf for secretarial assistance. This study was supported by NIH Grant DK 19682 and Project AASC-99-01 from the Competitive Grants Program of the Maryland Agricultural Experiment Station.
ER, endoplasmic reticulum; RER, rough endoplasmic reticulum; BiP, binding protein; bp, base pair(s); kb, kilobase pairs; GR, glucocorticoid receptor; PR, progesteron receptor; ETF, epidermal growth factor receptor-specific transcription factor; Jak/Stat (Janus Kinase/signal transducer and activator of transcription); CAT, chloramphenicol acetyltransferase; G3PDH, glyceraldehyde 3 phosphate dehydrogenase.
Number
Exon
Sequence at exon-intron junctiona
Intron
Location in cDNA (nt)
Size (bp)
5[prime] Donor exon
Intron
3[prime] Acceptor exon
Number
Size (bp)
Amino acid interruptedb
Typec
1
5[prime]NC-346
5[prime]NC+346
TCACAG
gtaacc......tcccag
GACTGA
A
92
G-116
I
2
347-577
230
CCCCAG
gtcagg......acccag
GCCTCA
B
479
Q-192
O
3
578-775
197
TGGCAG
gtaact......ttcaag
CTACAA
C
150
S-259
II
4
776-3[prime]NC
1726+3[prime]NC
Discussion
TGGATTTTAGCAGACTGGCTGTTCTTTATTATTAGAAGGATCTTGGAGAAAGCCATTCATTTTC,
<----- ----->
covering the segment -1164 to -1101 has two underlined hexads. While the right hand hexad has the perfect consensus for binding by the glucocorticoid receptor (GR), the left hand hexad has the critical G and C required for binding by the receptor (the critical bases in the hexads are shown in italicized bold face); further, the hexads are separated by three nucleotides, a stringent spacing requirement for binding by the dimeric GR (Stöcklin et al., 1996). This part of the promoter sequence, while not perfect to bind the dimeric GR, is an excellent candidate for binding by this receptor.
-1399 AAATAATACCTGTTCTACAGCTCTGTCCTGATAGTATAAAGT -1359,
-----> ----->
could potentially represent an enhancer that binds monomeric forms of GR and interacts with Stat(s) bound to remote sites in the promoter. The segment has the direct repeat hexads of glucocorticoid receptor half-sites separated by seven nucleotides (DR7).
TGGACTTCTTGGAATTAAGGGACT...,
-----> ----->
in rat [beta]-casein gene promoter (Lechner et al., 1997). A functional analysis via cotransfection studies in COS cells after introducing mutations in these GR-binding half-sites and other GR-binding half-sites, removed as far away as ~140 bp upstream from the Stat5-binding site in the [beta]-casein promoter, dramatically reduced the synergism between prolactin and hydrocortisone for the activation of the reporter gene (Lechner et al., 1997).Materials and methods
Acknowledgments
Abbreviations
References
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: jnl.info{at}oup.co.uk
Last modification: 15 Jul 1999
Copyright©Oxford University Press, 1999.